Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable caffeine for post-cholecystectomy pain after laparoscopic surgery
IRCT20221205056716N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of caffeine in postoperative pain (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Pain score and Pethidine dosage. Started May 2023; status: completed.
02
Drugs
caffeine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20221205056716N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20221205056716N1.